CD8 T cell reprogramming to boost antiviral potential against chronic infection

These studies are relevant for public health since they focus on the development of novel immune therapies aiming at the cure of a prevalent chronic viral infection (hepatitis B virus [HBV]). Specifically, we will evaluate if CD8 T cell reprogramming with a GSK3 inhibitor improves their functional capacity and antiviral potential against HBV.